Method for prepn. of 1 alpha, 25-dihydroxy vitamin Da medicine and anologue
The invention relates to 1α, 25-dihydroxy vitamin D3 and 1 α-hydroxy vitamin D3 preparation method. 1 α, 25-dihydroxy vitamin D3 is a molecular formula with the following three-dimensional structure of the steroid compound. It exists in other animal body and in the human body, and can be separated from it. 1 α-hydroxy vitamin D3 analogs of is, after entering the human body, after liver , kidney, the role of the small intestine, can be converted to 1α, 25-dihydroxy vitamin D3. 1 α, 25-dihydroxy vitamin D3 1 α-hydroxy vitamin D3 Laboratory-scale production is completed, the amount of each time 0.5 micrograms, clinical demonstrate that 1α, 25-dihydroxy vitamin D3 vivo active metabolites is, play a very good in vivo clinical effect of the, shown in the following respects: 1. the kidney of the metabolism of the necessary material, inhibitors of osteoporosis bone mass reduction 2 ., 3. the treatment of chronic kidney, parathyroid function is low, rickets, osteomalacia, metabolic abnormalities VD bone caused by the lesion, with 4. were secreted hyperspienism inhibition of thyroid, 5. regulating serum calcium concentration. A purpose of this invention is to provide a synthetic preparation of 1α, 25-dihydroxy vitamin D3 and 1 α-hydroxy vitamin D3 method of the medicament. After long-term and careful study, the present inventors developed a more simple and convenient, the method of synthesis through the short. Than danske Leo Company, Corporation of Japan pharmaceutical emperor person method is more simple and more convenient, with a route short, high yield and the like. The United States, Japan sold on the market the hydroxy vitamin D3 types of medicament is 2 a, a to 1α, 25-dihydroxy vitamin D3, another kind is the 1 α-hydroxy vitamin D3 According to the invention, the reaction process of the II and I through the reaction process can be easily make the above-mentioned two kinds of vitamin D3 kinds of medicament. I reaction process (and the reaction procedure II) Type used in the solid-line-arrow is disposed above the plane of the paper to key, dashed-line arrow means is located below the paper plane of the key. R is a protecting group for hydroxyl group SiMe3, SiMe2 Bu-t, SiPh2 Bu-t, CO2 Me, MOM, THP, MEM, such as EE; R ' for OR, H; For ' R C1-C6 alkyl; X is CH2 Cl, CH2 Br, CH2 I, CH2 OMs, CH2 OTs, CHO; Y is H, PhSO2; Z is H, =O; X ' as OH, H; Y ' is H, PhSO2; Z ' for =O, H; X 'to OCS2 R' According to the method provided by the invention, the compound 3 (substituted steroid part) with compound 4 in the reaction is performed in the presence of an alkali reagent, branched chain extension compound prepared surface 5. Alkali reagent can be sodium methoxide, sodium ethoxide, lithium hydride , sodium hydride, potassium hydride, n-BuLi, diisopropylamine based lithium, wherein two isopropylamines based lithium is preferred. This reaction may be the in -80 under to [...] such as hexane, at room temperature, anhydrous ether, cyclohexane, anhydrous ethanol, anhydrous methanol, dichloromethane, carbon tetrachloride, tetrahydrofuran or dioxane in organic solvent for five minutes to 48 hours. Furthermore, the reducing agent for compound 5 for reaction. The reduction reaction can be room temperature to the reflux temperature of the solvent, in the routine in the aforementioned organic solvent stirring five minutes to 48 hours, the reaction is complete, to make structured compound 6 or compound 7. Compound 7 with the 1-substituted imidazole thioester (compound 8) in the presence of alkali agent or alkali-free reagent for the reaction to prepare the compound 9. Alkali reagent can be sodium methoxide, sodium ethoxide, lithium hydride , sodium hydride, potassium hydride, wherein the sodium hydride is preferred. This reaction may be in the 0 to [...] under the reflux temperature of the solvent, such as hexane, anhydrous ethyl ether, cyclohexane, anhydrous ethanol, benzene, anhydrous methanol, dichloromethane, carbon tetrachloride, tetrahydrofuran or dioxane in organic solvent for five minutes to 48 hours. Furthermore, using Bu3 SnH/AIBN reagent the steroid compound 9 to free radical reaction. The free radical reaction may be the room temperature to the reflux temperature of the solvent in the conventional organic solvent is hexane, anhydrous ethyl ether, cyclohexane, anhydrous ethanol, anhydrous methanol, dichloromethane, tetrahydrofuran or dioxane, benzene, toluene for five minutes to 48 hours. Thus make the compound 6. The compound 6 with Lewis acid in conventional organic solvent is hexane, anhydrous ethyl ether, cyclohexane, anhydrous ethanol, anhydrous methanol, dichloromethane, carbon tetrachloride, tetrahydrofuran or dioxane, benzene, toluene, the hydrolysis reaction, so as to prepare compound 10. This reaction may be the in -80 to [...] carried out under reflux temperature of the solvent 1 minutes to 48 hours. Lewis acid can be Bu4 NF, HF, HCl, AeOH, CF3 CO3 H, TsOH, HF·Py, PPTs, BF3 ·Et2 O. Finally, the presence of the organic solvent, compound 10 carries on the actinic reaction. but is the benzene of the organic solvent, ethanol, toluene, acetonitrile. The in -40 [...] to the solvent reflux temperature of the reduction reaction is carried on under 1 minutes to 24 hours. Necessary, by chromatography to separate hydroxy vitamin D3 and impurity. The chromatography can use the silica gel column chromatography or Sephadex column chromatography, can be used the eluent chloroform/hexane/methanol mixed liquid. The following, we will combine the best embodiment of the method of the present invention for further details. Embodiment 1 A) compound 5b synthesis of In compound 4b (13.06g), diisopropylamine (6.93 ml) with tetrahydrofuran (20 ml) in solution, the -20 under [...] , adding n-BuLi (1.6M, 80 ml), stirring 20 minutes, adding compound 3b (8.2g), HMPA (8.18 ml) with tetrahydrofuran (20 ml) solution, the reaction at -20 under [...] , stirring 3 hours later, by adding ethyl acetate dilution, crude product is purified by fast chromatography to obtain compound 5b (9.1g, yield 91%). Elemental analysis measured value C68.12 H9.80 B) compound 6b synthesis of In compound 5b (9.1g) tetrahydrofuran/methanol (21 the [...] 43, 64 ml) mixed solution is added with 9% sodium-amalgam (25g). The reaction is stirred at room temperature 2 hours after dilution into and water, the aqueous phase with benzene extraction, the organic phase drying, concentration. Crude product by fast chromatography (benzene: ethyl acetate 100 the [...] 4) purification to obtain the pure product compound 6b (7.18g, yield 95%). Elemental analysis measured value C71.39 H11.02 C) compound 10b synthesis of In compound 6b (7.18g) chloroform (200 ml) solution, adding TaOH·H2 O (23.8g), 95% ethanol (580 ml). Reaction heating reflux for 60 minutes, cooling to room temperature, diluted adds the chloroform , and water washing the response industry uses ammonium chloride aqueous solution, the aqueous phase is extracted with chloroform. Organic phase dried, concentrated. Crude product by fast chromatography (benzene: ethyl acetate 75 the [...] 25) to obtain the pure product compound 10b (3.82g, yield 88%) Elemental analysis measured value C77.77 H10.59 D) preparation of 1α, 25-dihydroxy vitamin D3 Repeat embodiment 1, f) steps, can make 1α, 25-dihydroxy vitamin D3 embodiment 2 A) compound 4 object 5a synthesis of The LDA (1.6M, 7 . 26 ml, 11 . 6mmol) THF of (20 ml) in, the -78 under [...] , by adding compound 4a (1g, 11.6mmol) THF of (15 ml) solution, the mixture in this temperature stirring 30 minutes. Then add commercial compound 3a (4.46g, 9 . 7mmol) THF of (20 ml) solution, the in -78 under [...] , stirring 2 hours, then in this solution, add saturated ammonium chloride solution. The aqueous phase is extracted several times with ethyl acetate. The organic phase is dried with anhydrous sodium sulfate, evaporate solvent, residue through the rapid silica gel column chromatography (elution the medicinal preparation is the benzene : ethyl acetate 85 the [...] 15 of the mixed solution) purification, get compound 5a (4.81g) yield 91%. Elemental analysis measured value C68.06 H8.42 B) compound 7a synthesis of In compound 5a (3g, 5.5mmol) of dichloromethane (20 ml) and methanol (15 ml) is added to the mixed solution of sodium boron hydrogen (0.6g, 15 . 8mmol), this solution stirring at room temperature for 2 hours, then adding methylene chloride and water to dilute, aqueous phase dichloromethane by extraction, the organic phase using water washing, drying by anhydrous sodium sulfate, evaporate the solvent, crude product by fast chromatography (elution the medicinal preparation is the benzene : ethyl acetate 75 the [...] 25 of the mixed solution) to obtain the pure product 7a (2.4g, 80%)and unreacted raw material compound 5a. Elemental analysis measured value C67.78 H8.86 C) compound 9a synthesis of In compound 7a (2.3g, 4 . 2mmol) tetrahydrofuran (20 ml) solution, added at room temperature sodium hydride (60%, 0 . 34g, 14.8mmol), stirring 1 hour later, by adding 1-(methyl disulfide carboxyl) imidazole, compound 8a (2.34g, 14 . 8mmol) tetrahydrofuran (20 ml) solution, stirring 2 hours. Diluted into, and add saturated ammonium chloride solution, the aqueous phase with benzene extraction, the organic phase with water washing. Drying, after concentration, crude product by fast chromatography (elution the medicinal preparation is the benzene : ethyl acetate 100 the [...] 5 of the mixed solution) to obtain the pure product 9a (2.75g, yield 90%) Elemental analysis measured value C57.58 H7.11 D) compound 6a synthesis of In compound 9a (2.66g 3.66mmol), n-Bu3 SnH (12.2 ml 45.7mmol), AIBN (586 mg, 3 . 66mmol) and toluene (100 ml) of the mixed solution is heated to reflux 30 minutes later, evaporate the solvent, crude product by fast chromatography (elution the medicinal preparation is the benzene : ethyl acetate 93 the [...] 7 of the mixed solution) to obtain the pure product compound 6a (1.38, yield 81%). Elemental analysis measured value C72.03 H9.32 E) compound 10a synthesis of The compound 10a (1.53g, 2 . 97mmol) in dichloromethane (25 ml) solution, adding 5% KOH/MEOH solution (170 ml), mixed liquid is heating reflux for 60 minutes, to remove solvent, diluted with chloroform. Organic reinforced with ammonium chloride aqueous solution and water washing. Organic phase drying, concentrating, the crude products of fast chromatography (eluting agent is ethanol: chlorofrom 10 the [...] 90 of the mixed solution) to obtain the pure product compound 10a (1.02g, yield 86%). Elemental analysis measured value C80.89 H11.03 F) preparation of 1 α-hydroxy vitamin D3 The compound 10a (50 mg 0.125mmol) benzene/ethanol (the 150 [...] 20,170 ml) mixed solution, into the high-purity argon. In 0 the under [...] , using 100W high-pressure mercury lamp through the Vycor filter until the compound 10a exertion end, to remove the solvent, the residue Sephadex LH-20 chromatography (chloroform/n-hexane/methanol 70 the [...] the 30 [...] 7) and get crude previtamin D3 (18 mg), crude product is dissolved in 95% ethanol, placing 14 days later, the Sephadex LH-20 chromatography (chloroform/n-hexane/methanol 70 the [...] the 30 [...] 7) after the purification, get the pure product 1 α-hydroxy vitamin D3 12.5 mg, 25% yield). Elemental analysis measured value C80.99 H11.10 This invention adopts the existing technology with the synthesis of 1α, 25-dihydroxy vitamin D3 or 1 α-hydroxy vitamin D3 different synthetic pathway, so as to synthesize the International market for sale of expensive hydroxy vitamin D3 kinds of medicament. Furthermore, the preparation method of this invention also has the advantages of low cost, mild reaction conditions, notably the synthetic pathway the characteristics of short, and the like. A process for preparing medicine 1 alpha, 25-dihydroxyl VD3 and 1 alpha-hydroxyl VD3 includes introducing branch chain part to 1,3-dihydroxyl steroid, desulfurizing, dehydroxylating to obtain protected precursors of 1 alpha, 25-dihydroxyl VD3 and 1 alpha-hydroxyl VD3, hydrolysis and photochemical treatment. Its advantages are preparing two medicines at same time, gentle reaction condition, shorter process and easy synthesis. 1. a kind of preparation of the following having optical activity of 1α, 25-dihydroxy vitamin D3 medicine and 1 α-hydroxy vitamin D3 method of drug 1 α, 25-dihydroxy vitamin D3 1 α-hydroxy vitamin D3 which is characterized in that the method comprises: A) formula 3 substituted steroid part and the type 4 reaction of branched part Wherein R is a protecting group for hydroxyl group SiMe3, SiMe2 Bu-t, SiPh2 Bu-t, CO2 Me, MOM, THP, MEM, EE, ; X for CH2 Cl, CH2 Br, CH2 I, CH2 OMs, CH2 OTs or CHO, ; Y to PhSO2 or H; Z is H or =O; R ' OR or H the; reaction formula 5 product. Wherein X ' is H or OH; Y ' for H or PhSO2; Z ' for H or =O. B) formula 5 compound reduction reaction with the reducing agent, to make the following formula 6 or formula 7 compound. C) formula 7 compounds of the formula 8 of the 1-substituted imidazole thioester reaction is carried out Wherein R ' is C1-C6 alkyl, reaction formula can be obtained 9 product Wherein X 'to OCS2 R' D) formula 9 compound and Bu3 SnH/AlBN the system results in the type reaction can be 6 E) of formula 6 compound reaction of the hydroxy protecting groups can be formula 10 compound Wherein R ' is OH or H F) formula 10 can be prepared by photochemical treatment of compound 1 α-hydroxy vitamin D3 or 1a, 25-dihydroxy vitamin D3 2. method according to Claim 1, characterized in that in the step a) is carried out in the presence of the subtractive of the reagent. Alkaline reagent is lithium hydride , sodium hydride, potassium hydride, sodium methoxide, sodium ethoxide, n-butyl lithium, isobutyl lithium , uncle butyl lithium , diisopropylamine based lithium, lithium hydroxide, sodium hydroxide, potassium hydroxide. 3. method according to Claim 2, characterized in that step a) the reaction is carried out in an organic solvent. 4. method according to Claim 1, characterized in that step b) is carried out in the presence of a reducing agent. 5. method according to Claim 4, characterized in that step b) reduction reaction is carried out in an organic solvent. The temperature further is -78 to [...] reflux temperature of the solvent. 6. method according to Claim 1, characterized in that step c) is performed in the presence of the alkaline reagent. Alkaline reagent is lithium hydride , sodium hydride, potassium hydride, sodium methoxide, sodium ethoxide, n-butyl lithium, isobutyl lithium , uncle butyl lithium , diisopropylamine based lithium, lithium hydroxide, sodium hydroxide, potassium hydroxide. 7. method according to Claim 6, characterized in that step c) is carried out in an organic solvent. The temperature further is -78 to [...] reflux temperature of the solvent. 8. method according to Claim 1, characterized in that step d) reaction with reagent Bn3 SnH/AlBN the presence of, the carried out in an organic solvent, the temperature further to the reflux temperature of the solvent. 9. method according to Claim 1, characterized in that the step e) of removing a protecting group in reaction is carried out in an organic solvent. 10. method according to Claim 9, characterized in that the protecting group of the reagent is escapes the hydroxyl HF, HCl, AcOH, CF3 CO2 H, TsOH, HF·Py, PPTs, Bu4 NF, BF3 ·OEt2. 11. method according to Claim 1, characterized in that step f) is in the organic solvent, high-pressure mercury lamp of the illumination. 12. method according to Claim 1, characterized in that step a) in the branched part